Verastem, Inc. (VSTM)
NASDAQ: VSTM · Real-Time Price · USD
7.49
-0.01 (-0.13%)
At close: Apr 25, 2025, 4:00 PM
7.46
-0.03 (-0.40%)
After-hours: Apr 25, 2025, 5:52 PM EDT
Verastem Employees
Verastem had 78 employees as of December 31, 2024. The number of employees increased by 5 or 6.85% compared to the previous year.
Employees
78
Change (1Y)
5
Growth (1Y)
6.85%
Revenue / Employee
$128,205
Profits / Employee
-$1,674,833
Market Cap
386.17M
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
UnitedHealth Group | 400,000 |
Johnson & Johnson | 138,100 |
Thermo Fisher Scientific | 125,000 |
Abbott Laboratories | 114,000 |
AstraZeneca | 92,900 |
Novartis AG | 75,883 |
Merck & Co. | 75,000 |
VSTM News
- 2 days ago - Verastem Oncology Announces $75 million Private Placement - Business Wire
- 4 days ago - Verastem Oncology Announces U.S. IND Clearance of VS-7375, Oral KRAS G12D (ON/OFF) Inhibitor, Enabling Phase 1/2a Trial in Advanced Solid Tumors - Business Wire
- 17 days ago - Verastem: RAMP-203 Study Could Be Next Big Win For Avutometinib Combination - Seeking Alpha
- 20 days ago - Verastem Oncology Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - Business Wire
- 4 weeks ago - Verastem Oncology Announces Multiple Presentations Focused on RAS/MAPK Pathway Inhibition at AACR Annual Meeting 2025 - Business Wire
- 5 weeks ago - Verastem Oncology Reports Fourth Quarter and Full Year 2024 Financial Results and Highlights Recent Business Updates - Business Wire
- 2 months ago - Verastem Oncology Announces Multiple Data Presentations at Society of Gynecologic Oncology 2025 Annual Meeting on Women's Cancer - Business Wire
- 3 months ago - Verastem Oncology to Present at the Guggenheim SMID Cap Biotech Conference - Business Wire